Biomarker-Driven Prescribing in Oncology

Biomarker-Driven Prescribing in Oncology

Time:December 18-18, 2014

Venue:Latin America

Organizer: Decision Resources Group

The Impact of the Current Access Environment on the Uptake of Biomarker-Driven Prescribing in Oncology in Latin America

In this webinar, Decision Resources Group will focus on key findings of these Physician and Payer Forum reports: Biomarker-Driven Prescribing in Oncology: Stakeholder Dynamics in Mexico and Argentina for Breast Cancer, NSCLC, CRC and Malignant Melanoma and Biomarker-Driven Prescribing in Oncology: Stakeholder Dynamics in Brazil for Breast Cancer, NSCLC, CRC and Malignant Melanoma

Date & Time
Thursday, December 18, 2014
10 a.m. EDT | 4 p.m. CET

Find answers to the questions that matter

To what extent has biomarker-driven prescribing penetrated the indications under study, and how do prescribing patterns vary by country?

What does the current market access environment look like in Brazil, Mexico and Argentina for biomarker-driven therapies for select cancers?

What do emerging agents with biomarkers need to demonstrate to encourage uptake over existing non-targeted treatments?

How will prescribing patterns change with the launch of new targeted therapies?